BioMarin Pharmaceutical Inc.

Q4 2017 13F Holders

Symbol
BMRN
CUSIP
09061G101
Type
Equity
Class
COM
Num filers
442
Total reported value, excl. options
$15.8B
Manager Report Date Value ($000) Shares